• Info
  • Insider Ownership

Insider Trading & Ownership of Jason P. Rhodes

Location
Cambridge, MA
Summary
The estimated net worth of Jason P. Rhodes is at least $26,714,165 dollars as of 09 Feb 2026. Jason P. Rhodes is the Director of Dyne Therapeutics, Inc. and owns shares of Dyne Therapeutics, Inc. (DYN) stock worth about $26.44M. Jason P. Rhodes is the Director of Generation Bio Co. and owns shares of Generation Bio Co. (GBIO) stock worth about $275.4K.
Signature
/s/ Shawna-Gay White, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Jason P. Rhodes and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Jason P. Rhodes has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $26,714,165.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Dyne Therapeutics, Inc. ($26,438,765).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Jason P. Rhodes

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DYN Dyne Therapeutics, Inc. Director $26,438,765 30 May 2025
GBIO Generation Bio Co. Director $275,400 09 Feb 2026
IRON Gemini Therapeutics, Inc. /DE Director, 10%+ Owner 04 Oct 2021
REPL Replimune Group, Inc. Director 01 Apr 2022

Insider Transactions Reported by Jason P. Rhodes:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored